+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Active Pharmaceutical Ingredients Market Research Report by Type, Synthesis, Manufacturer, Therapeutic Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989866
  • Report
  • April 2022
  • Region: Global
  • 209 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbvie Inc.
  • Astrazeneca
  • BASF SE
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • Glaxosmithkline PLC
The Global Active Pharmaceutical Ingredients Market size was estimated at USD 200.25 billion in 2021, USD 213.08 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.58% to reach USD 293.65 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients.
  • Based on Synthesis, the market was studied across Biotech Active Pharmaceutical Ingredients and Synthetic Active Pharmaceutical Ingredients.
  • Based on Manufacturer, the market was studied across Captive API Manufacturers and Merchant API Manufacturers.
  • Based on Therapeutic Application, the market was studied across Cardiovascular Diseases, Communicable Diseases, Diabetes, Oncology, Pain Management, and Respiratory Diseases.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Active Pharmaceutical Ingredients market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Active Pharmaceutical Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Active Pharmaceutical Ingredients Market, including Abbvie Inc., API Pharma Tech, Astrazeneca, Aurobindo Pharma, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, Inc., Dr. Reddy's Laboratories Ltd, ELI Lilly and Company, F. Hoffmann-La Roche, Glaxosmithkline PLC, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Active Pharmaceutical Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Active Pharmaceutical Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Active Pharmaceutical Ingredients Market?
4. What is the competitive strategic window for opportunities in the Global Active Pharmaceutical Ingredients Market?
5. What are the technology trends and regulatory frameworks in the Global Active Pharmaceutical Ingredients Market?
6. What is the market share of the leading vendors in the Global Active Pharmaceutical Ingredients Market?
7. What modes and strategic moves are considered suitable for entering the Global Active Pharmaceutical Ingredients Market?
Frequently Asked Questions about the Global Active Pharmaceutical Ingredients Market

What is the estimated value of the Global Active Pharmaceutical Ingredients Market?

The Global Active Pharmaceutical Ingredients Market was estimated to be valued at $200.3 Billion in 2021.

What is the growth rate of the Global Active Pharmaceutical Ingredients Market?

The growth rate of the Global Active Pharmaceutical Ingredients Market is 6.5%, with an estimated value of $293.7 Billion by 2027.

What is the forecasted size of the Global Active Pharmaceutical Ingredients Market?

The Global Active Pharmaceutical Ingredients Market is estimated to be worth $293.7 Billion by 2027.

Who are the key companies in the Global Active Pharmaceutical Ingredients Market?

Key companies in the Global Active Pharmaceutical Ingredients Market include Abbvie Inc., API Pharma Tech, Astrazeneca, Aurobindo Pharma, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Boehringer Ingelheim, Bristol and Cipla, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc.
  • Astrazeneca
  • BASF SE
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • Glaxosmithkline PLC

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of chronic diseases
5.1.1.2. Growing importance of generics coupled with uptakes of biopharmaceuticals
5.1.1.3. Technological advancements in active pharmaceutical ingredients
5.1.1.4. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
5.1.1.5. Rising focus on precision medicine and growing investment
5.1.2. Restraints
5.1.2.1. Unsupportive price control policies for drug across various countries
5.1.2.2. Increasing availability of counterfeit drugs
5.1.3. Opportunities
5.1.3.1. Emergence of biosimilars
5.1.3.2. Highly effective active pharmaceutical ingredients
5.1.4. Challenges
5.1.4.1. High cost associated with the manufacturing process
5.1.4.2. Concern associated with the product differentiation
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Active Pharmaceutical Ingredients Market, by Type
6.1. Introduction
6.2. Generic Active Pharmaceutical Ingredients
6.3. Innovative Active Pharmaceutical Ingredients
7. Active Pharmaceutical Ingredients Market, by Synthesis
7.1. Introduction
7.2. Biotech Active Pharmaceutical Ingredients
7.3. Synthetic Active Pharmaceutical Ingredients
8. Active Pharmaceutical Ingredients Market, by Manufacturer
8.1. Introduction
8.2. Captive API Manufacturers
8.3. Merchant API Manufacturers
9. Active Pharmaceutical Ingredients Market, by Therapeutic Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Communicable Diseases
9.4. Diabetes
9.5. Oncology
9.6. Pain Management
9.7. Respiratory Diseases
10. Americas Active Pharmaceutical Ingredients Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Active Pharmaceutical Ingredients Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Active Pharmaceutical Ingredients Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbvie Inc.
14.2. API Pharma Tech
14.3. Astrazeneca
14.4. Aurobindo Pharma
14.5. BASF SE
14.6. BDR Pharmaceuticals Internationals Pvt. Ltd.
14.7. Boehringer Ingelheim
14.8. Bristol-Myers Squibb
14.9. Cipla, Inc.
14.10. Dr. Reddy's Laboratories Ltd
14.11. ELI Lilly and Company
14.12. F. Hoffmann-La Roche
14.13. Glaxosmithkline PLC
14.14. Merck & Co., Inc.
14.15. Mylan N.V.
14.16. Novartis AG
14.17. Pfizer, Inc.
14.18. Sanofi
14.19. Sun Pharmaceutical Industries Ltd
14.20. Teva Pharmaceutical Industries Ltd
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DYNAMICS
FIGURE 2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (%)
FIGURE 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2027
FIGURE 12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, 2019-2027 (USD BILLION)
FIGURE 13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2021 VS 2027 (%)
FIGURE 17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2021 VS 2027 (USD BILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2027
FIGURE 19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2021 VS 2027 (%)
FIGURE 24. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2027
FIGURE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD BILLION)
TABLE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 16. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 17. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 18. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 29. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 34. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD BILLION)
TABLE 48. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD BILLION)
TABLE 50. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 53. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 55. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 58. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 60. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 63. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: SCORES
TABLE 98. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: BUSINESS STRATEGY
TABLE 99. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PRODUCT SATISFACTION
TABLE 100. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RANKING
TABLE 101. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 102. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MERGER & ACQUISITION
TABLE 103. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 104. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 105. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INVESTMENT & FUNDING
TABLE 106. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 107. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbvie Inc.
  • API Pharma Tech
  • Astrazeneca
  • Aurobindo Pharma
  • BASF SE
  • BDR Pharmaceuticals Internationals Pvt. Ltd.
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cipla, Inc.
  • Dr. Reddy's Laboratories Ltd
  • ELI Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...